V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Director of Biostatistics

Quantitative Biology & BiostatisticsUpdated on Nov 11
Full-timeWaltham, MA, USAHybrid

About the Job

Requirements

  • A PhD or equivalent degree with at least 8 years of relevant work experience in biotech, pharma, regulatory agencies, or clinical research organizations, or an MS or equivalent degree with at least 12 years of relevant experience.
  • Excellent statistical knowledge and the ability to apply it to solve scientific and clinical problems.
  • Proficiency in scientific computing and programming using SAS, R, or Python, and implementation of advanced statistical analysis, data manipulation, graphing, and simulation.
  • Working knowledge of relevant FDA, EU, and ICH guidelines and regulations.
  • Demonstrated proficiency in statistical processes including CRF review, development of randomization lists, development of statistical analysis plans, development of CDISC submission packages (SDTM, ADaM, define.xml, and reviewer guides), development of analysis outputs, and review of clinical study reports.
  • Experience managing external vendors.
  • Strong written and verbal communication skills.
  • Ability to manage multiple projects in a fast-paced environment.
  • Ability to collaborate effectively in a dynamic, cross-functional matrix environment.
  • Strong commitment to ethical standards.
  • Proficiency with Microsoft Office, including Word, PowerPoint, Excel, Outlook, and SharePoint.
  • Ability to travel up to 10%.

Responsibilities

  • Serve as the biostatistics leader and partner to the clinical development team, determining clinical study strategies and managing teams to deliver high-quality results on time.
  • Apply innovative statistical thinking and fit-for-purpose statistical methods to improve the probability of success for clinical development programs.
  • Collaborate with internal and external data management stakeholders.
  • Collaborate with internal and external stakeholders to ensure effective quantitative approaches are used to collect and analyze a wide variety of data types.
  • Guide and manage contractors and consultants, and manage and mentor supporting team members to ensure high-quality, timely deliverables.
  • Oversee statistical sections of clinical development plans, protocols, statistical analysis plans, and key specifications for statistical programming implementation of analyses.
  • Plan, manage, and track biostatistics activities, timelines, and resources, and ensure operational excellence.
  • Interact with regulatory agencies and address statistical questions and requests.
  • Review or author standard operating procedures and work instructions related to biostatistics practices.
  • Collaborate with and manage internal and external functions, including contract research organizations, software vendors, and clinical development partners, to meet project timelines and goals.
  • Manage a functional or project budget, allocate company resources according to project needs, set priorities, and ensure consistency and adherence to standards.
  • Represent Viridian at professional societies and in industry-wide technical discussions.

Desired Qualifications

  • Experience in rare disease therapeutics clinical development.
  • Extensive experience managing teams and engaging contract research organizations, vendors, and relationship management.
  • Prior experience supporting one or more successful BLA, NDA, or MAA submissions and participating in regulatory agency meetings.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs